Drug-Induced Dyskinesia Market

Future Market Insights

Key Insight

The drug-induced dyskinesia market is projected to grow from USD 434.5 million in 2025 to USD 658.8 million by 2035, at a CAGR of 4.3%. VMAT2 Inhibitors will dominate with a 42.5% market share, while hospitals will lead the end user segment with a 55.0% share.

August 04, 2025

Anurag Sharma

288 Pages

Cite this Report

Drug-Induced Dyskinesia Market

https://www.futuremarketinsights.com/reports/drug-induced-dyskinesia-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Lannett Company
SteriMax Inc
Sun Pharmaceutical Industries Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Drug-Induced Dyskinesia Market

Key Players

Similar Industry Reports